have been previously used in renal experiments to alter the plasma colloid osmotic pressure, blood volume, and hematocrit in studies examining the control of salt and water excretion (1, 3, 12, 29, 30) and renal hemodynamics (1, 3, 20, 2 l), but distinction has not always been made between the renal effects due solely to the oncotic properties and those due to other properties (11). However, renal hyperemia following dextran loading has been a relatively consistent observation.
This effect has been attributed to the overall blood volume expansion (3, 5, 17) , to the decreased hematocrit and viscosity of the blood (19, 2 l), or to arteriolar vasodilation caused in some indirect manner by the dextran loading (1). On the other hand, the effect of dextran infusions on urinary excretion is unclear, with reports varying from diuresis (1, 5, 12, 17, 28) to oliguria (10, 19, 25, 30 Analysis of data was performed with the aid of a PDP-9 digital computer using standard statistical methods. A computer graphics program was utilized to plot the pressure-flow and pressure-resistance curves.
RESULTS
Renal hemodynamic and urine flow responses to hyperoncotic dextran loading. The changes in the steady-state values of arterial pressure, intrarenal venous pressure, renal blood flow, intrarenal resistance, glomerular filtration rate, urine flow, blood hematocrit, and plasma colloid osmotic pressure following infusions of the hyperoncotic solutions of dextran were evaluated. Figure 1 shows the responses of renal blood flow and glomerular filtration rate plotted against the increase in plasma colloid osmotic pressure. In each experiment there was a marked increase in renal blood flow following the infusion of dextran.
In every instance, this increase in renal blood flow was associated with an increase in plasma colloid osmotic pressure and a decrease in blood hematocrit.
The changes in glomerular filtration rate were not as consistent as the renal blood flow changes, and the individual experiments showed variable results. In some experiments, urine flow decreased to such an extent that GFR determinations by standard clearance methods were not possible. between the increases in colloid osmotic pressure and the increases in renal blood flow revealed a correlation coefficient (r) of 0.7 1 and a regression coefficient (b) of 1.38 % increase in renal blood flow per 1 % increase in colloid osmotic pressure. These values were significant at the 5 % level.
Renal autoregulatory responses to hyperoncotic loading. In four experiments, the effect of the hyperoncotic dextran loading on the renal autoregulatory phenomenon was investigated. All of the experiments responded in a similar manner with only slight quantitative differences. Figure 3 illustrates the results of one of these experiments in detail. Renal blood flow is plotted both as a function of renal arterial pressure and of the renal arterial-intrarenal venous pressure diffence. The difference between these curves is attributed to the effects of passive venous pressure changes (22). In the top portion of Fig. 3 , the intrarenal resistance is plotted as a function of the arterial pressure. In each of the graphs, the control curve demonstrates the presence of typical autoregulatory behavior. Infusion of 400 ml of a hyperoncotic dextran solution resulted in a marked diminution of renal autoregulatory capability with pressure-flow and pressureresistance relationships indicative of a nearly passive system. With infusion of about 200 ml of the dextran solution, the observed responses were less marked. Renal blood flow increased, but autoregulatory behavior could still be observed at the higher arterial pressures. Under these more moderate conditions, the autoregulation range appeared to be reset at a higher pressure level due to the fall in the base-line resist- Consideration of the mechanisms involved in the renal blood flow autoregulating system encompasses three aspects. First, there must be some sensor capable of recognizing the resultant effects of an alteration in blood flow, and capable of generating a signal in response to these alterations. Second, some transmitting system must exist to carry that signal from the sensor element to the site of regulation. Third, there must be some effector element that responds to the signal by altering renal resistance to return blood flow to the regulated level. Disruption of any of these three components will compromise the ability of the system to adjust renal vascular resistance to compensate for altered renal perfusion pressure. This in turn allows renal blood flow to vary -to a greater than normal degree with perfusion pressure could be expected to cause a resetting of the base-line flow but allow the system to maintain some ability to adjust resistance with variations in arterial pressure. When a specific disturba rice results in decreased resistance, the autoregulatory pressure range would be progressively offset to higher arterial pressures. Under these conditions, autoregulatory behavior rnight not be observed at arterial pressures normally achieved in these preparations. Fig. 4 , capability for adjustment of vascular resistance was still present following the dextran infusions, despite reduction of steady-state resistance and loss of autoregulatory capacity. Because the effector component of the system was apparently intact, the observed disruption of blood flow autoregulation must have resulted from some effect on either the sensing or the transmitting component. Two other observations distinguish the responses to dextran infusion from the resx)onses to infusion of direct vasodilator agents. First, urine flow rate was not increased, despite the increase in blood flow. Second, blood flow at perfusion pressures below the autoregulatory range was unchanged or decreased. These are in direct contrast to the effect of infusion of direct vasodilators.
Thus, it would appear that the mechanism of renal vasodilation in response to the dextran infusions is more complex than that due to vasodilator infusions. rate in turn would result in decreased tubular flow and perhaps alter the composition of fluid delivered to some segment of the tubular system (14). The increased peritubular capillary oncotic pressure could augment this effect by increasing the net peritubular fluid reabsorption (6, 16, 29, 32) . This alteration in tubular fluid flow or tubular fluid composition could be responsible for elicitation of some feedback signal to effect a decreased preglomerular resistance and an elevated glomerular hydrostatic pressure. In this manner, the increased oncotic pressure would be offset and filtration rate would return toward normal. To the extent that they can be compared, the findings of the present study are in general agreement with those in which concentrated albumin solutions have been infused (4, 8, 18, 26) . It has generally been assumed that the concentrated albumin in some manner exerts its effects through changes in the plasma colloid osmotic pressure. The decreased urine flow under these conditions could be partially due to an increased peritubular capillary oncotic pressure which is thought to increase net fluid reabsorption (6, 16, 25, 29, 30 , 3 1). Leakage of dextran across the glomerular capillaries into the tubular system has been observed previously (7, 10, 11, 28) and could contribute in some indirect manner to the responses observed. Because of the polydispersity of molecular weight, this appears to be a problem common to all dextrans (13). It was apparent in these experiments that some dextran leakage occurred since the urine became quite viscous following the dextran infusions. Measurements of urine colloid osmotic pressures substantiated this observation. Following filtration of dextran molecules, continued reabsorption of tubular fluid could result in concentration of dextran in the tubules, possibly increasing the viscosity of
